Renal parenchymal tumors and lymphoma in the same patient: Case series and review of the literature

American Journal of Hematology

Volumn 81, Issue 4, 2006, Pages 271-280

  Kunthur, Anuradha ^a   Wiernik, Peter H ^a   Dutcher, Janice P ^a,b  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b Our Lady of Mercy Cancer Center   (United States)

Author keywords

Lymphoma; Renal carcinoma; Second malignancies; Simultaneous tumors

Indexed keywords

BEVACIZUMAB; CHLORMETHINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; INTERLEUKIN 2; PREDNISONE; PROCARBAZINE; RITUXIMAB; VINCRISTINE;

ADULT; AGED; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; FEMALE; GENETIC PREDISPOSITION; HODGKIN DISEASE; HUMAN; IMMUNE DYSREGULATION; KIDNEY CARCINOMA; LYMPHOMA; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; REVIEW; SECOND CANCER; SEX DIFFERENCE; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; ENVIRONMENTAL EXPOSURE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KIDNEY NEOPLASMS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPHOMA; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; SEX FACTORS; TREATMENT OUTCOME;

EID: 33645727465     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20533     Document Type: Review

References (35)

1. Travis LB, Curtis RE, Boice JD, et al. Second cancers following non-Hodgkin's lymphoma. Cancer 1991;67:2002-2009.
2. Travis LB, Curtis RE, Glimelius B. et al. Second cancers among long-term survivors of non-Hodgkin's lymphoma. J Natl Cancer Inst 1993;85:1932-1937.
3. Ohsawa M, Hashimoto M, Yasunaga Y, Shingu N. Characteristics of non-Hodgkin's lymphoma complicated by renal cell malignancies. Oncology 1998;55:482-486.
4. Anderson CM, Puszatai L, Palmer JL, Cabanillas F. Coincidental renal cell carcinoma and non-Hodgkin's lymphoma: the M. D. Anderson experience and review of literature. J Urol 1998;159:714-716.
5. Tihan T, Filippa D. Coexistence of renal cell carcinoma and malignant lymphoma: a causal relationship or coincidental occurrence? Cancer 1996;77:2325-2339.
6. Nishikubo C, Kunkel LA, Figlin R, Belldegrun A, Wang H. An association between renal cell carcinoma and lymphoid malignancies: a case series of eight patients. Cancer 1996;78:2421-2427.
7. Shah IA, Haddad FS, Gani OS, Alfsen CC. An association between renal cell carcinoma and lymphoid malignancies: a case series of eight patients. Cancer 1997;80:1004-1005.
8. Bernie JE, Albers L, Baird S, Parsons CL. Synchronous ipsilateral renal adenocarcinoma, transitional cell carcinoma of the renal pelvis and metastatic renal lymphoma. J Urol 2000;164:773-774.
9. Shah SA, Ormerod AD. Husain, et al. Primary cutaneous CD30 (Ki-1) positive anaplastic large cell lymphoma associated with renal cell carcinoma. Br J Dermatol 1999;140:971-972.
10. Kurtz JE, Andres E, Maloisel F, Herbrecht R. Renal cell carcinoma and type B lymphomatous proliferation: a fortuitous association? Rev Med Intern 1999;20:329-332.
11. Wang BY, Strauchen JA, Rabinowiz, D. Renal cell carcinoma with intravascular lymphomatosis. A case report of unusual collision tumours with review of literature. Arch Pathol Lab Med 2001;125:1239-1241.
12. Yagisawa K, Ohno Y, Toba K, et al. Three cases of malignant lymphoma accompanied by renal cell carcinoma. Rinsho Ketsueki 2001;42:616-620.
13. Barista I. An association between renal call carcinoma and lymphoid malignancies. Cancer 1997;80:1004-1005.
14. Dores GM, Metayer C, Curtis RE, et al. Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. J Clin Oncol 2002;20:3484-3494.
15. Ng AK, Bernardo MVP, Weller E, et al. Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. Blood 2002;100:1989-1996.
16. Abrahamsen AF, Andersen A, Nome O, et al. Long-term risk of second malignancy after treatment of Hodgkin's disease: the influence of treatment, age and follow-up time. Ann Oncol 2002;13:1786-1791.
17. Bhatia S, Yasui Y, Robison LL, et al. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group. J Clin Oncol 2003;21:4386-4394.
18. Sparano JA, Wiernik PH, Leaf A, Dutcher JP. Infusional cyclophosphamide, doxorubicin and etoposide in relapsed and resistant non-Hodgkin's lymphoma: evidence for a schedule dependent effect favoring infusional administration of chemotherapy. J Clin Oncol 1993;11:1071-1089.
19. Czene K, Hemminki K. Familial papillary renal cell tumors and subsequent cancers: a nationwide epidemiological study from Sweden. J Urol 2003;169:1271-1275.
20. Crocetti E, Carli P. Risk of second primary cancers, other than melanoma, in an Italian population-based cohort of cutaneous malignant melanoma patients. Eur J Cancer Prev 2004;13:33-37.
21. Lens MB, Newton-Bishop JA. An association between cutaneous melanoma and non-Hodgkin's lymphoma: pooled analysis of published data with a review. Ann Oncol 2005;16(3):460-465 (Epub 10 Jan 2005).
22. Pyrhonen S, Mantyjarvi R, Tykka H, et al. BK and Herpes simplex virus antibodies in renal cell carcinoma. Med Biol 1978;56:194-200.
23. Rohwedder A, Philips B, Malfetano J, et al. Vulvar malignant melanoma associated with human papillomavirus DNA: report of two cases and review of literature. Am J Dermatopathol 2002;24:230-240.
24. Kamel D, Turpeenniemi-Hujanen T, Vahakangas K, Paakko P. Proliferating cell nuclear antigen but not p53 or human papillomavirus DNA correlates with advanced clinical stage of renal cell carcinoma. Histopathology 1994;25:333-347.
25. Grce M, Furcic I, Hrascan R, et al. Human papillomaviruses are not associated with renal carcinoma. Anticancer Res 1997;17:2193-2196.
26. Kadish AS, Ho GY, Burk RD, et al. Lymphoproliferative responses to human papilloma virus type 16 proteins E6 and E7: outcome of HPV infection and associated neoplasia. J Natl Cancer Inst 1997;89:1285-1293.
27. O'Connor SR, Tan JH, Walewska R, et al. Angiotropic lymphoma occurring in a lacrimal sac oncocytoma. J Clin Pathol 2002;10:787-788.
28. Etkind PR, Du J, Khan A, et al. Mouse mammary tumor virus-like ENV gene sequences in human breast tumors and in a lymphoma of a breast cancer patient. Clin Cancer Res 2000;6:1273-1278.
29. Wang Y, Pelisson I, Melana SM, et al. Detection of MMTV-like LTR and LTR-env gene sequences in human breast cancer. Int J Oncol 2001;18:1041-1044.
30. Wiernik PH, Hu X-P, Ratech H, Etkind PR. Non-Hodgkin's lymphoma in women with breast cancer. Cancer J Sci Am 2000;6:336-342.
31. Etkind PR, Stewart AF, Dorai T, et al. Clonal isolation of different strains of mouse mammary tumor virus-like DNA sequences from both the breast tumors and non-Hodgkin's lymphomas of individual patients diagnosed with both malignancies. Clin Cancer Res 2004;10:5656-5664.
32. Basombrio MA, Mayer AM, Rivell C. An increased incidence of lymphoma in mice inoculated with human breast cancer extracts. Arch Geschwulstforsch 1977;47:679-684.
33. Anglard P, Tory K, Brauch H, et al. Molecular analysis of genetic changes in the origin and development of renal cell carcinoma. Cancer Res 1991;51:1071-1077.
34. Reiter RB, Anglard P, Gnarra JR, et al. Chromosome 17p deletions and p53 mutations in renal cell carcinoma. Cancer Res 1993;53:3092-3097.
35. Alqahtani MH, Hammond DW, Goepel JR, Goyns MH. Cytogenetic analysis of non-Hodgkin's lymphomas by ratio-painting and comparative genomic hybridization reveals unsuspected chromosomal abnormalities. Leuk Lymphoma 1999;35:325-337.